Literature DB >> 9257369

Fatal diffuse alveolar damage from bird fanciers' lung.

S Tasaka1, M Kanazawa, C Kawai, K Soejima, K Yamaguchi, A Takata, C Torikata, J Hata.   

Abstract

A 68-year-old man, who had continuing exposure to budgerigars, developed fatal acute respiratory failure following years of slowly progressive pulmonary deterioration. His lung function was characterized first by mild airflow obstruction and later by progressive loss of lung volume. Computed tomography showed progressive development of pulmonary fibrosis and honeycombing. His serum disclosed precipitins to pigeon antigen. During his final illness his chest radiograph showed widespread patchy consolidation. At autopsy, his lungs revealed left lower lobe bronchopneumonia, fibrosis and honeycombing at the bases and widespread evidence of diffuse alveolar damage with organized exudate in some alveoli. To our knowledge, this is the second reported fatality due to acute alveolar injury in bird fanciers' lung.

Entities:  

Mesh:

Year:  1997        PMID: 9257369     DOI: 10.1159/000196694

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  3 in total

1.  A sphingosine-1-phosphate receptor 1 agonist inhibits tertiary lymphoid tissue reactivation and hypersensitivity in the lung.

Authors:  C A Huppé; P Blais Lecours; A Lechasseur; D R Gendron; A M Lemay; E Y Bissonnette; M R Blanchet; C Duchaine; M C Morissette; H Rosen; D Marsolais
Journal:  Mucosal Immunol       Date:  2017-04-19       Impact factor: 7.313

2.  Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias.

Authors:  Y Ohtani; S Saiki; M Kitaichi; Y Usui; N Inase; U Costabel; Y Yoshizawa
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

3.  An autopsy case of bird-related chronic hypersensitivity pneumonitis presenting with repeated acute exacerbation.

Authors:  Hironori Mikumo; Toyoshi Yanagihara; Naoki Hamada; Mikiko Hashisako; Kayo Ijichi; Kunihiro Suzuki; Eiji Harada; Yasunori Shikada; Yoshinao Oda; Yoichi Nakanishi
Journal:  Respir Med Case Rep       Date:  2018-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.